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Introduction
In vitro assays using hepatic microsomes are a powerful tool for both drug discovery applications and human health risk assessment (Obach, 1997) . Microsomes are the metabolically active subcellular tissue fraction of the endoplasmic reticulum (ER) and exist primarily as vesicles. Extensive research with hepatic microsomes has focused on the cytochrome P450 (CYP) superfamily of enzymes, which are located on the periphery of the microsome vesicle (Cribb et al., 2005) . In vivo, the cytosolic pentose pathway primarily supplies CYP enzymes with NADPH for oxidative transformation. In vitro microsomal assays, which are devoid of the cytosolic fraction, are routinely supplied NADPH by either direct addition of NADPH or use of an NADPH-regenerating system (NRS), consisting of β -NADP + , glucose-6-phosphaste (G6P), and glucose-6-phosphate dehydrogenase (G6PDH).
In contrast to CYP enzymes, a chemical's susceptibility to enzymatic processes inside the lumen (intraluminal) depends on the selective transport of cofactors across the ER membrane. Intraluminal carbonyl reduction is an important process for the normal function of various endogenous substrates and many pharmaceutical agents and pesticides utilize carbonyl moieties in their mode of action. While many cytosolic carbonyl-reducing enzymes have been identified, carbonyl reductase in hepatic microsomes is mainly attributed to 11β-HSD1, a short-chain dehyrdrogenase-reductase (SDR). 11β-HSD1 is an intraluminal NADPH-dependent enzyme that has been wellcharacterized for the interconversion of the glucocorticoid hormone cortisone to cortisol and is considered the primary microsomal reductase for carbonyl-containing therapeutics and pesticides (Oppermann, 2007) .
This article has not been copyedited and formatted. The final version may differ from this version. is then directly coupled to 11β-HSD1 activity Piccirella et al., 2006) .
Recently, we reported on the 11β-HSD1-mediated carbonyl reduction of the broad spectrum 1,2,4-triazole fungicide triadimefon to triadimenol (Kenneke et al., 2008) . The current study focuses on the contrasting effects of NADPH and NRS on the kinetic transformation of carbonyl containing xenobiotics in hepatic microsomes. We examined the CYP-mediated transformation of propiconazole and the intraluminal carbonyl reduction of cortisone and the xenobiotic triadimefon with direct addition of NADPH and NRS. In addition, in silico predictions based on chemical binding score and carbonyl to hydride-NADP distance were used to identify other 11β-HSD1 substrates that may yield discrepant reaction kinetics depending on the use of either NADPH or NRS.
This article has not been copyedited and formatted. The final version may differ from this version. Vitro Technologies (Baltimore, MD) and stored at -80 °C until use. All microsomal incubations (0.30 mg protein) were conducted using the same lot of microsomes and assayed as previously described (Kenneke et al., 2008) . Briefly, metabolism assays were initiated by the addition of either 250 μ L of NRS or NADPH to the microsomal suspension. All alamethicin assays were conducted at 50 μ g/mg of microsomal protein and were incubated for ten minutes before initiation of the reaction (Piccirella et al., 2006) . Abiotic microsomal controls were conducted with addition of the parent compound and omission of either NADPH or G6P from the NRS. (Table 1) were built in MOE and optimized using the MMFFx 2 (Halgren and Nachbar, 1996) force-field as implemented in MOE . All docking experiments for substrates listed in Table 1 were This article has not been copyedited and formatted. The final version may differ from this version. . The natural cortisone reductase activity was measured on the basis of cortisol formation at saturating NADPH levels to ensure maximum enzyme activity was achieved at the selected substrate concentration (137 µM).
Influence of Cofactors on Triadimenol and Cortisol Formation.
Triadimenol formation in assays with NRS displayed greater than a four-fold increase in reaction velocity relative to NADPH; cortisone reduction to cortisol was enhanced over two-fold (Fig. 2) . Carbonyl reductase activity was also detected for both triadimefon and cortisone during sole addition of G6P. Cortisol formation in the system containing G6P alone Disruption of microsome ER membrane cofactor transport with the pore-forming alamethicin was conducted with NRS and NADPH using triadimefon and propiconazole.
Triadimenol formation in assays containing NADPH with alamethicin displayed activity levels near the NRS (Fig.3) , while alamethicin showed no adverse effect on CYPmediated propiconazole metabolism.
In Silico Prediction of Triadimefon Binding to Enzymatic Systems.
Triadimefon metabolism was reported to proceed through both carbonyl reduction via 11β-HSD1 (Kenneke et al., 2008) and CYP 3A-mediated oxidation of the t-butyl group (Barton et al., 2006) . Using a molecular docking approach, we compared the prequilibrium process of triadimefon binding to 11β-HSD1 (PDB ID: 2IRW) and CYP 3A4 (PD BID: 2V0M). A lower energy binding score and less sterically hindered distance between the minimum energy poses of triadimefon against each target system's catalytic active site indicates a more favorable carbonyl-reduction pathway (see supplemental information). Other carbonyl-containing substrates that may yield discrepant reaction kinetics using either NADPH or NRS were calculated based on 11β-HSD1 binding score and carbonyl to hydride-NADP distance (Table 1) .
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Discussion:
Carbonyl containing xenobiotics, which may be susceptible to oxidative CYP pathway(s) positioned on the periphery of the ER, may serve as substrates for 11β-HSD1-reductase activity located within the ER lumen. Although both processes are NADPHdependent, intraluminal carbonyl reduction relies on cofactor transport across the ER membrane . Our investigation of triadimefon biotransformation assessed with NADPH and NRS using hepatic microsomes resulted in contrasting kinetics ( Fig.1) . Michaelis-Menten data analysis of triadimenol formation with the NRS matrix showed nearly a five-fold increase in V max compared to the direct addition of NADPH while the K M values remained constant. Thus, calculation of hepatic clearance based on the ratio of the kinetic parameters V max / K M would yield a five-fold difference between NRS and NADPH (Obach, 1997) . The implications of these findings are significant as in vitro kinetic measurements serve a critical component to physiologically based models used in chemical risk assessment.
Assays conducted with the native 11β-HSD1 substrate, cortisone, in the presence of NRS and NADPH paralleled the triadimefon results in displaying a lower rate of carbonyl-reductase activity with NADPH (Fig.2) . In contrast, the CYP-mediated oxidative transformation of propiconazole, which occurs on the periphery of the microsome vesicle, demonstrated the same activity levels with either NRS or NADPH (Fig.3) . These results indicate that direct addition of NADPH and use of an NRS may
give differing results based on enzyme location with respect to the ER membrane.
In order to further assess the influence of NRS on carbonyl reduction, a combination of NRS cofactor components were evaluated with triadimefon and cortisone.
This article has not been copyedited and formatted. The final version may differ from this version. A significant finding was observed with cortisol and triadimenol formation occurring in incubation matrices containing only G6P, whereas no propiconazole transformation was observed. These results support the role of an intraluminal H6PDH that utilizes G6P to generate NADPH for direct use by 11β-HSD1 in the reduction of cortisone to cortisol.
Intraluminal H6PDH activity is maintained by a specific transporter (G6PT) for G6P entrance into the ER, which contains a separate NADP + pool for NADPH generation within the lumen of the microsome vesicle (Piccirella et al., 2006) . The H6PDH production of NADPH remained compartmentalized and did not influence the extraluminal CYP-mediated metabolism of propiconazole.
The pyridine nucleotides NADP + and NADPH are considered relatively impermeable to the ER membrane, which is supported by the limited triadimefon and cortisone carbonyl-reductase activity observed with the sole addition of NADPH . The low activity observed with the direct addition of NADPH is likely the result of extravesicular exposure of 11 β -HSD1 through a non-intact portion of the vesicle (Fig.2) . In addition, a report has shown that both NADP + and NADPH can constrict the microsome vesicle through increased osmotic pressure, which may allow non-specific entrance of the pyridine nucleotides through transport channels into the lumen (Piccirella et al., 2006) . Thus, our results of increased reactivity levels for G6P matrices amended with either NADP + or NADPH may indicate the effects of enhanced intraluminal entrance of the pyridine nucleotides on H6PDH and 11 β -HSD1 enzymes, respectively.
Permeation of microsome vesicles with the pore-forming peptide alamethicin has been used to overcome the ER membrane barrier to study intraluminal processes This article has not been copyedited and formatted. The final version may differ from this version. (Piccirella et al., 2006) . Triadimenol formation in microsomal assays containing NADPH with alamethicin increased by four-fold compared to the system without, and the overall reactivity approached the level measured with NRS (Fig.3) . Increased triadimenol formation was measured in the NRS system containing alamethicin compared to the system without, which may be attributed to increased NADPH access to the lumen.
Alamethicin had no effect on propiconazole activity measured with either NRS or NADPH as the CYP process is located outside the microsme vesicle.
Our findings of triadimenol formation in the presence of NADPH contrast a previous study that identified CYP 3A4 oxidation as the predominant enzyme in the substrate depletion of triadimefon with NADPH, although product identification was not reported (Barton et al., 2006) . Using a molecular docking approach, we compared binding score and distance metric comparisons of triadimefon with human 11β-HSD1
and CYP 3A4 to determine the most favorable enzymatic pathway. Our calculations indicate that triadimefon has a much lower energy and more favorable docked pose for 11β-HSD1 compared to CYP 3A4, and thus carbonyl-reduction would be favored over CYP oxidation. These results agree with in vivo findings showing the reduction of triadimefon to triadimenol and the formation of its glucuronic acid as the major metabolite (Roberts and Hutson, 1999) .
In addition, we assessed other xenobiotics that may pose discrepant reaction kinetics depending on the use of either NRS or NADPH by comparing binding score and carbonyl to hydride-NADP distance of known 11β-HSD1 substrates (Table 1. ). The wellstudied carbonyl-containing therapeutic, warfarin, which had a favorable docked pose compared with known 11β-HSD1 substrates, has been previously assayed with human This article has not been copyedited and formatted. The final version may differ from this version. hepatic microsomes using both NADPH and NRS (Hermans and Thijssen, 1989; Obach, 1997 All systems contained MgCl 2 with percent activity calculated relative to system A.
Results are means +/-95 % confidence interval for triplicate determinations. 
